Best Seller Gp000095: Muc1(126-149)-stn(144) In Multiple Colors [VW1Mmcxi]

Best Seller Gp000095: Muc1(126-149)-stn(144) In Multiple Colors [VW1Mmcxi] Synthetic Glycopeptide

The GP000095 product is a high-quality synthetic glycopeptide designed for research applications. This product features a MUC1 (UniProt ID P15941) fragment from the variable number tandem repeat (TR) domain, specifically the Pro126-Gly149 sequence, with a length of 24 amino acids. The unique aspect of this fragment is the incorporation of the tumour-associated carbohydrate antigen Sialyl Tn (STn) at position Thr144, providing a valuable tool for studying tumour biology and related diseases.

• High purity: Ensures reliable and consistent results in research experiments.
• Specificity: The inclusion of the STn antigen allows for targeted research on tumour-associated antigens.

Product Specifications and Technical Details

The GP000095 MUC1(126-149)-STn(144) glycopeptide is synthesized with a carboxylic acid at the C-terminus, making it suitable for various biochemical analyses. The sequence of the glycopeptide is as follows: PAPGSTAPPAHGVTSAPDT*RPAPG-OH, where T* represents the sialyl Tn (STn) residue. This synthetic peptide is ideal for applications such as immunohistochemistry, enzyme-linked immunosorbent assays (ELISAs), and as a control in research studies.

• Sequence: PAPGSTAPPAHGVTSAPDT*RPAPG-OH
• Length: 24 amino acids
• Application: Suitable for immunohistochemistry, ELISA, and research control

Practical Applications and Target Audience

The GP000095 MUC1(126-149)-STn(144) glycopeptide is a versatile research tool with wide applications in oncology and immunology. Researchers studying tumour biology, cancer markers, and carbohydrate antigens will find this product invaluable. Its use in diagnostic tests and as a research control can enhance the accuracy and reliability of experimental results. This product is particularly beneficial for researchers in academic institutions, biotech companies, and pharmaceutical organizations focused on cancer research and development.

• Applications: Oncology, immunology, diagnostic tests, and research controls
• Target Audience: Academic researchers, biotech and pharmaceutical companies